← Back to Clinical Trials
Recruiting NCT06467552

NCT06467552 Effects of Nutritional Support on Postoperative Delirium

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06467552
Status Recruiting
Phase
Sponsor Yonsei University
Condition Postoperative Delirium
Study Type INTERVENTIONAL
Enrollment 314 participants
Start Date 2024-06
Primary Completion 2028-05-12

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
control groupNucare Curact group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 314 participants in total. It began in 2024-06 with a primary completion date of 2028-05-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a prospective, single-center, randomized controlled trial to compare whether applying nutritional supplementation therapy before and after surgery in elderly patients aged 65 years or older undergoing non-cardiac surgery can reduce the incidence of postoperative delirium.

Eligibility Criteria

Inclusion Criteria: * Elderly patients aged 65 and above. * Patients undergoing non-cardiac major surgery in thoracic surgery, lung cancer surgery, multi-level spinal surgery in neurosurgery and orthopedics, or liver cancer surgery in hepatobiliary and pancreatic surgery, under general anesthesia with an expected surgery duration of 2 hours or more. * Patients scheduled for arterial catheterization. * Patients who are able to take oral intake from postoperative day #1. Exclusion Criteria: * Patients with uncontrolled systemic conditions such as diabetes, hypertension, renal disease, liver disease, and other systemic illnesses. * Those with visual impairment. * Patients with cognitive impairment based on the Mini-Mental State Examination for Dementia Screening criteria. * Individuals experiencing difficulty in communication. * Those diagnosed with neurological disorders (such as brain hemorrhage, stroke, brain tumor, dementia, Parkinson's disease, cognitive impairment, depression, etc.). * Patients diagnosed with alcohol or substance addiction. * Patients with cancelled scheduled surgeries. * Patients undergoing minor surgeries with expected anesthesia durations of less than 2 hours.

Contact & Investigator

Central Contact

Bon-Nyeo koo, MD

✉ koobn@yuhs.ac

📞 82-10-9982-4469

Frequently Asked Questions

Who can join the NCT06467552 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Postoperative Delirium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06467552 currently recruiting?

Yes, NCT06467552 is actively recruiting participants. Contact the research team at koobn@yuhs.ac for enrollment information.

Where is the NCT06467552 trial being conducted?

This trial is being conducted at Seoul, South Korea.

Who is sponsoring the NCT06467552 clinical trial?

NCT06467552 is sponsored by Yonsei University. The trial plans to enroll 314 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology